
    
      Participants were randomized in 1:1 ratio into one of the following drug regime:

      Group (I): "sildenafil citrate group" This group consisted of 22 women who received single
      oral dose of 50 mg sildenafil citrate.

      Group (II): "placebo group" This group consisted of 22 women who received single oral dose of
      placebo. All participants were evaluated by ultrasound once they admitted and again after
      2-hours following administration of either of the treatment tablets. One sonographer was
      allocated to evaluate all mothers included in the study.
    
  